Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

Published:2016-04 Issue:4 Volume:31 Page:848-855
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Lédinghen Victor de¹²,Wong Grace Lai-Hung³⁴,Vergniol Julien¹,Chan Henry Lik-Yuen³⁴,Hiriart Jean-Baptiste¹,Chan Anthony Wing-Hung⁵,Chermak Faiza¹,Choi Paul Cheung-Lung⁵,Foucher Juliette¹,Chan Carmen Ka-Man¹²,Merrouche Wassil¹,Chim Angel Mei-Ling¹²,Le Bail Brigitte²⁶,Wong Vincent Wai-Sun³⁴

Affiliation:

1. Investigation Center of Liver Fibrosis, Haut-Lévêque Hospital; Bordeaux University Hospital; Pessac France

2. INSERM U1053, Bordeaux University; Bordeaux France

3. State Key Laboratory of Digestive Disease; The Chinese University of Hong Kong; Hong Kong China

4. Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Hong Kong China

5. Department of Anatomical and Cellular Pathology; The Chinese University of Hong Kong; Hong Kong China

6. Department of Pathology, Pellegrin Hospital; Bordeaux University Hospital; Bordeaux France

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13219/fullpdf

Reference21 articles.

1. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011

2. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

3. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease;Wong;Clin Gastroenterol Hepatol,2006

4. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease;Wong;Aliment Pharmacol Ther,2006

5. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes;Sasso;Ultrasound Med Biol,2010

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reference values and associated factors of controlled attenuation parameter and liver stiffness in adults: A cross-sectional study;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

2. Overall and Sex-Specific Associations of Serum Lipid-Soluble Micronutrients with Metabolic Dysfunction-Associated Steatotic Liver Disease among Adults in the United States;Nutrients;2024-04-22

3. The Effect of Steatosis on Shear-Wave Velocity and Viscoelastic Properties Related to Liver Fibrosis Progression in Rat Models;Ultrasound in Medicine & Biology;2024-04

4. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

5. Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction‐associated steatotic liver disease;Liver International;2024-02-14